GHK-Cu vs PT-141 (Bremelanotide)
Overview
GHK-Cu is primarily a healing & recovery peptide, while PT-141 (Bremelanotide) is used for cosmetic & skin.
This page compares GHK-Cu and PT-141 (Bremelanotide) across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| GHK-Cu | PT-141 (Bremelanotide) | |
|---|---|---|
| Category | Healing & Recovery | Cosmetic & Skin |
| Regulatory status (US) | Compounding (Rx) — Apr 2026 | Research use only |
| Typical dosage | 1-3 mg | 1.75 mg |
| Frequency | daily | as needed |
| Reported benefits | Wound healing, collagen synthesis, anti-inflammatory, antioxidant effects, tissue remodeling | Enhanced libido, sexual function |
| Reported side effects | Generally safe. Possible: mild skin irritation with topical use | Nausea, flushing, blood pressure changes |
Key differences
Primary use. GHK-Cu is categorised under Healing & Recovery, while PT-141 (Bremelanotide) falls under Cosmetic & Skin. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. GHK-Cu: not FDA-approved; compounding permitted with a prescription as of April 2026. PT-141 (Bremelanotide): not FDA-approved; treated as a research compound.
Dosing. GHK-Cu is typically dosed at 1-3 mg (daily). PT-141 (Bremelanotide) is typically dosed at 1.75 mg (as needed).
Can you stack them?
Some protocols combine peptides, but stacking GHK-Cu and PT-141 (Bremelanotide) has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between GHK-Cu and PT-141 (Bremelanotide)?
- GHK-Cu is primarily a healing & recovery peptide, while PT-141 (Bremelanotide) is used for cosmetic & skin. GHK-Cu is not FDA-approved; compounding permitted with a prescription (as of April 2026), whereas PT-141 (Bremelanotide) is not FDA-approved; generally classified as a research compound.
- What is GHK-Cu used for?
- Wound healing, skin regeneration.
- What is PT-141 (Bremelanotide) used for?
- Libido enhancement peptide.
- Can you take GHK-Cu and PT-141 (Bremelanotide) together?
- Some users combine peptides within a single protocol, but stacking GHK-Cu and PT-141 (Bremelanotide) has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is GHK-Cu or PT-141 (Bremelanotide) FDA-approved?
- GHK-Cu is not FDA-approved; compounding permitted with a prescription (as of April 2026). PT-141 (Bremelanotide) is not FDA-approved; generally classified as a research compound.
Read the full articles
- GHK-Cu — full monograph: mechanism, research, dosing & references
- PT-141 (Bremelanotide) — full monograph: mechanism, research, dosing & references